Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 3230 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#3230, RRID:AB_2128522
- Product name
- Jak2 (D2E12) XP® Rabbit mAb
- Antibody type
- Monoclonal
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Storage
- -20°C
Submitted references ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells.
Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.
Confocal imaging studies cast doubt on nuclear localization of JAK2V617F.
Neuronal suppressor of cytokine signaling-3 deficiency enhances hypothalamic leptin-dependent phosphatidylinositol 3-kinase signaling.
Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation.
Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia.
Niederreiter L, Fritz TM, Adolph TE, Krismer AM, Offner FA, Tschurtschenthaler M, Flak MB, Hosomi S, Tomczak MF, Kaneider NC, Sarcevic E, Kempster SL, Raine T, Esser D, Rosenstiel P, Kohno K, Iwawaki T, Tilg H, Blumberg RS, Kaser A
The Journal of experimental medicine 2013 Sep 23;210(10):2041-56
The Journal of experimental medicine 2013 Sep 23;210(10):2041-56
Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.
Singh S, Verma R, Pradeep A, Leu K, Mortensen RB, Young PR, Oyasu M, Schatz PJ, Green JM, Wojchowski DM
PloS one 2012;7(1):e29064
PloS one 2012;7(1):e29064
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.
Pulikkan JA, Madera D, Xue L, Bradley P, Landrette SF, Kuo YH, Abbas S, Zhu LJ, Valk P, Castilla LH
Blood 2012 Jul 26;120(4):868-79
Blood 2012 Jul 26;120(4):868-79
Confocal imaging studies cast doubt on nuclear localization of JAK2V617F.
Girodon F, Steinkamp MP, Cleyrat C, Hermouet S, Wilson BS
Blood 2011 Sep 1;118(9):2633-4
Blood 2011 Sep 1;118(9):2633-4
Neuronal suppressor of cytokine signaling-3 deficiency enhances hypothalamic leptin-dependent phosphatidylinositol 3-kinase signaling.
Metlakunta AS, Sahu M, Yasukawa H, Dhillon SS, Belsham DD, Yoshimura A, Sahu A
American journal of physiology. Regulatory, integrative and comparative physiology 2011 May;300(5):R1185-93
American journal of physiology. Regulatory, integrative and comparative physiology 2011 May;300(5):R1185-93
Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation.
Bhattacharyya S, Zhao Y, Kay TW, Muglia LJ
Proceedings of the National Academy of Sciences of the United States of America 2011 Jun 7;108(23):9554-9
Proceedings of the National Academy of Sciences of the United States of America 2011 Jun 7;108(23):9554-9
Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia.
Rinaldi CR, Rinaldi P, Alagia A, Gemei M, Esposito N, Formiggini F, Martinelli V, Senyuk V, Nucifora G, Pane F
Blood 2010 Dec 23;116(26):6023-6
Blood 2010 Dec 23;116(26):6023-6
No comments: Submit comment
No validations: Submit validation data